- Investing Ideas
- /
- U.S. Top Stock Picks from Analysts
U.S. Top Stock Picks from Analysts
Results
1202
Companies which are more than 50% undervalued based on analyst price target.
1202 companies
ARB IOT Group
Market Cap: US$10.3m
Through its subsidiaries, provides Internet of Things (IoT) system solutions, and system integration and support services in Malaysia.
ARBB
US$5.83
7D
4.3%
1Y
-16.7%
PAVmed
Market Cap: US$10.2m
Engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States.
PAVM
US$0.37
7D
14.1%
1Y
-66.8%
Adaptimmune Therapeutics
Market Cap: US$10.0m
A commercial-stage biopharmaceutical company, provides novel cell therapies primarily to cancer patients in the United States and the United Kingdom.
ADAP.Y
US$0.038
7D
-20.0%
1Y
-94.8%
Creative Medical Technology Holdings
Market Cap: US$9.9m
A commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States.
CELZ
US$2.69
7D
-1.1%
1Y
9.8%
DSS
Market Cap: US$9.9m
Operates in the product packaging, biotechnology, commercial lending, securities and investment management, and direct marketing businesses in the United States.
DSS
US$1.09
7D
12.4%
1Y
11.2%
AEON Biopharma
Market Cap: US$9.9m
A clinical stage biopharmaceutical company, focuses on developing botulinum toxins.
AEON
US$0.85
7D
2.7%
1Y
-98.1%
Bolt Biotherapeutics
Market Cap: US$9.7m
A clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer.
BOLT
US$5.07
7D
1.6%
1Y
-59.9%
Tenon Medical
Market Cap: US$9.7m
A medical device company, engages in the development of implant for the treatment of severe lower back pain in the United States.
TNON
US$1.13
7D
-1.7%
1Y
-50.4%
BioRestorative Therapies
Market Cap: US$9.6m
Develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells.
BRTX
US$1.08
7D
2.7%
1Y
-28.1%
Biofrontera
Market Cap: US$9.5m
A biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.
BFRI
US$0.82
7D
2.9%
1Y
-18.3%
U Power
Market Cap: US$9.4m
Develops, manufactures, and sells new energy vehicles and battery swapping stations in the People’s Republic of China, Thailand, Southeast Asia, South America, Hong Kong SAR, and Macau SAR markets.
UCAR
US$1.94
7D
-0.8%
1Y
-69.5%
Banzai International
Market Cap: US$9.4m
A marketing technology company, provides data-driven marketing and sales solutions for various businesses in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
BNZI
US$1.39
7D
16.8%
1Y
-90.5%
OLB Group
Market Cap: US$9.3m
Provides integrated financial and transaction processing services for small and mid-sized merchants in the United States.
OLB
US$1.06
7D
1.0%
1Y
-43.0%
Healthy Choice Wellness
Market Cap: US$9.3m
Through its subsidiaries, operates natural and organic retail stores in the United States.
HCWC
US$0.62
7D
-0.6%
1Y
-59.5%
VerifyMe
Market Cap: US$9.2m
Offers brand protection and precision logistics solutions.
VRME
US$0.74
7D
3.3%
1Y
22.3%
IN8bio
Market Cap: US$9.2m
A clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of gamma-delta T cell product candidates for the treatment of cancer and autoimmune diseases.
INAB
US$1.98
7D
1.0%
1Y
-82.1%
Theriva Biologics
Market Cap: US$9.1m
A clinical-stage company, develops therapeutics to treat cancer and related diseases in areas of high unmet need in the United States.
TOVX
US$0.27
7D
16.9%
1Y
-80.4%
STRATA Skin Sciences
Market Cap: US$8.8m
A medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, China, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America.
SSKN
US$1.50
7D
15.4%
1Y
-51.3%
Movano
Market Cap: US$8.8m
A technology company, engages in the development of a platform to deliver healthcare solutions at the intersection of medical and consumer devices.
MOVE
US$10.50
7D
-10.5%
1Y
-78.8%
BIO-key International
Market Cap: US$8.8m
Develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education sectors in the United States and internationally.
BKYI
US$0.81
7D
-2.6%
1Y
-27.8%
Silynxcom
Market Cap: US$8.6m
Through its subsidiaries, develops, manufactures, markets, and sells ruggedized tactical communication headset devices and other communications accessories in Israel, Europe, Asia, the United States, and internationally.
SYNX
US$1.30
7D
2.4%
1Y
-50.0%
GT Biopharma
Market Cap: US$8.4m
A clinical stage biopharmaceutical company, engages in the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) and Tetra-specific Killer Engager (Dual Targeting TriKE) fusion protein immune cell engager technology platforms.
GTBP
US$0.79
7D
3.8%
1Y
-71.7%
Peraso
Market Cap: US$8.4m
A fabless semiconductor company, develops, markets, and sells semiconductor devices and antenna modules in North America, Hong Kong, Taiwan, and internationally.
PRSO
US$0.93
7D
6.4%
1Y
0.4%
Society Pass
Market Cap: US$8.4m
Acquires and operates fintech and e-commerce platforms and mobile applications for consumers and merchants in Indonesia, Vietnam, the Philippines, Singapore, the United States, Thailand, and Malaysia.
SOPA
US$1.37
7D
11.4%
1Y
44.2%
Alzamend Neuro
Market Cap: US$8.3m
A clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders.
ALZN
US$2.19
7D
5.3%
1Y
-80.5%
HeartSciences
Market Cap: US$8.2m
A medical technology company, focuses on applying AI-based technology to an ECG to expand and improve clinical usefulness.
HSCS
US$2.68
7D
5.9%
1Y
-18.3%
Acurx Pharmaceuticals
Market Cap: US$8.1m
A clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States.
ACXP
US$3.88
7D
-6.3%
1Y
-82.7%
Lucyd
Market Cap: US$8.0m
Engages in the development and sale of smart eyeglasses and sunglasses in North America.
LUCY
US$1.49
7D
-5.1%
1Y
-78.5%
Aprea Therapeutics
Market Cap: US$8.0m
A clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways.
APRE
US$1.26
7D
7.7%
1Y
-59.6%
Jet.AI
Market Cap: US$7.7m
Engages in the development and operation of private aviation platforms.
JTAI
US$1.97
7D
14.5%
1Y
-52.0%
Capstone Holding
Market Cap: US$7.6m
Engages in the distribution of masonry stone products in the Midwest and Northeast United States.
CAPS
US$0.91
7D
12.7%
1Y
n/a
Lottery.com
Market Cap: US$7.6m
Lottery.com Inc., doing business as Sports Entertainment Gaming Global Media Corporation, a digital publisher, provides lottery data results, jackpots, results, and other data.
SEGG
US$1.47
7D
3.5%
1Y
-54.6%
Adial Pharmaceuticals
Market Cap: US$7.5m
A clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders.
ADIL
US$0.31
7D
-3.2%
1Y
-70.7%
Newton Golf Company
Market Cap: US$7.5m
A technology-forward golf company, manufactures and sells golf products.
NWTG
US$1.65
7D
14.6%
1Y
-96.7%
22nd Century Group
Market Cap: US$7.4m
A tobacco products company, manufactures, distributes, and sells proprietary new reduced nicotine tobacco products in the United States.
XXII
US$1.06
7D
27.3%
1Y
-99.7%
Autonomix Medical
Market Cap: US$7.4m
A development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system.
AMIX
US$1.07
7D
-1.8%
1Y
-76.1%